Theriva Biologics
TOVX
TOVX
24 hedge funds and large institutions have $1.15M invested in Theriva Biologics in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$86.1K | |
| 2 | +$43.8K | |
| 3 | +$19.2K | |
| 4 |
VF
Virtu Financial
New York
|
+$19.1K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$17.5K |
Top Sellers
| 1 | -$256K | |
| 2 | -$34K | |
| 3 | -$25K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.02K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$5K |